What if curing cancer could cost 99% less in China?
Chinese biotech start-ups are going up against Western drug makers - and they could win A decade ago, treating cancer with personalised mRNA vaccines seemed like a US$1 million gamble per patient, a ...
scmp.com4d
Research into the low-cost treatments has shown promise, with around 60 clinical trials currently under way
They say these low-cost, high-impact viruses are showing promise in clinical trials – there are around 60 currently under way in China – and that they could transform cancer care. These ...
Reuters1mon
In China, a designer rethinks lingerie for women who have had breast cancer surgery
More than 350,000 women in China are diagnosed with breast cancer annually. Approached by a surgeon in 2019 who was seeking comfortable options for breast cancer patients, Yu was struck by the gap ...
ScienceAlert on MSN1mon
Lung Cancer Is Rising in Non-Smokers, And This Could Be Why
Digging into statistics from the Global Cancer Observatory (GLOBOCAN ... Again there's a link to east Asia and especially ...
UBS1y
APAC Focus: China ADC drugs - a rising force in cancer treatment
Are ADCs a promising therapeutic for China to race ahead of global competition? We believe the emerging ADC drug class holds substantial market potential as it demonstrates superior efficacy and more ...